Home-based exercise interventions incorporating cardiac rehabilitation principles for people with cancer: a systematic review and meta-analysis.

Ann MedSep 29, 2026 (epub)
Clinical ResearchOncology (Medical)Cardiology

Petr Winnige, Filip Dosbaba, Martin Hartman et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated home-based exercise interventions incorporating cardiac rehabilitation principles in adults with cancer. Nine randomized controlled trials involving 632 participants were analyzed. The findings indicated that home-based exercise significantly improved cardiorespiratory fitness (SMD 0.42) and health-related quality of life (SMD 0.63), suggesting it is a feasible alternative to center-based rehabilitation.

Key findings

  • Home-based exercise improved cardiorespiratory fitness with a standardized mean difference of 0.42.
  • Health-related quality of life also improved, with a standardized mean difference of 0.63.
  • Adherence to home-based exercise exceeded 75% in most studies.
  • Dropout rates were reported at 15.2%.

Why it matters

Given the increased cardiovascular risk in cancer patients, accessible home-based exercise programs may provide significant benefits in fitness and quality of life, potentially improving overall patient outcomes.

What to keep in mind

Incomplete adverse-event reporting limits the ability to draw firm safety conclusions.

Source

PubMed · PMID 42811812

Published in Ann Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.